Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial -

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions

1620240700515254272

EuroIntervention

The “PROgnostic Value of Precision Medicine in Patients With Myocardial Infarction and Non-obStructive Coronary artEries” aims to refine the treatment algorithm for MINOCA patients and to test the prognostic value of a targeted therapeutic approach. https://t.co/ytnTHd56Oh https://t.co/ytnTHd56Oh - view on twitter

See more from EuroIntervention